OLYMPIA, WA. – As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges state lawmakers to prioritize legislation that ensures biomarker testing is appropriately covered by more insurance plans, including Apple Health,
The following originally appeared in the Albany Times Union on January 9, 2023.
Kentucky Can and Must Do Better When it Comes to Reducing the Cancer Burden
As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.
Kentucky Can and Must Do Better When it Comes to Reducing the Cancer Burden
As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.
ALBANY, NY – DECEMBER 12, 2022 – The American Cancer Society Cancer Action Network (ACS CAN) and Santa Clause join children throughout New York in preparing a Christmas wish list, to be delivered tomorrow by Old Saint Nick to legislators in Albany.
The following was originally published in the Empire Report on December 6, 2022.
The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence.
Today, the Rhode Island Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.